You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CART%20Cell%20Therapy

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Wuhan (PD-1/PD-L1 inhibitor)

Suspended
  • Non Small Cell Lung Cancer
  • PD-1/PD-L1 inhibitor
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated to Tongji Medical College of Huazhong
Apr 6, 2021

Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)

Not yet recruiting
  • Acute Leukemia in Remission
  • +6 more
  • Fecal Microbiota Transplantation
  • Amiens, France
  • +19 more
Oct 18, 2022

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

Enrolling by invitation
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumor Grade 1
  • Iowa City, Iowa
    The University of Iowa
Dec 9, 2022

Acne, Transgenderism Trial in Ratchathewi (Testosterone)

Completed
  • Acne
  • Transgenderism
  • Ratchathewi, Bangkok, Thailand
    Division of Dermatology, Department of Internal Medicine, Facult
Nov 27, 2023

Prostate Cancer Trial in Philadelphia (Proton Beam Radiation Therapy, Quality-of-Life assessment, Questionnaire Administration)

Terminated
  • Prostate Cancer
  • Proton Beam Radiation Therapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 30, 2023

Genetic Determinants of Clindamycin/Rifampin Interaction

Completed
  • VA Drug Interaction
    • Paris, France
      Groupe Hospitalier Diaconesses Croix Saint Simon
    Oct 24, 2022

    Psoriasis Vulgaris Trial in San Francisco (Tildrakizumab Prefilled Syringe)

    Not yet recruiting
    • Psoriasis Vulgaris
    • Tildrakizumab Prefilled Syringe
    • San Francisco, California
      University of California, San Francisco
    May 20, 2022

    Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in Duarte, Irvine, Sacramento (ET140202 autologous T cell product)

    Terminated
    • Hepatocellular Carcinoma
    • +3 more
    • ET140202 autologous T cell product
    • Duarte, California
    • +2 more
    Apr 14, 2021

    Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

    Not yet recruiting
    • Leber Hereditary Optic Neuropathy (LHON)
    • NFS-02 Injection
    • (no location specified)
    Apr 6, 2023

    Head Neck Cancer Trial in London, Wales (Olaparib, Cisplatin, IMRT)

    Active, not recruiting
    • Head and Neck Cancer
    • London, United Kingdom
    • +2 more
    Nov 1, 2022

    NSCLC Trial in Guangzhou (HA121-28 tablet)

    Recruiting
    • NSCLC
    • HA121-28 tablet
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Centre
    Aug 2, 2022

    90Y Resin Micropheres for Refractory Colorectal Cancer Liver

    Recruiting
    • Liver Metastasis Colon Cancer
      • Aarhus N, Danmark, Denmark
        Department of Oncology, Aarhus University Hospital
      Feb 14, 2022

      Amyotrophic Lateral Sclerosis, ALS Trial in Seoul (HYNR-CS inj, Control group)

      Completed
      Has Results
      • Amyotrophic Lateral Sclerosis
      • ALS
      • HYNR-CS inj
      • Control group
      • Seoul, Korea, Republic of
        Hanyang University Hospital
      Mar 15, 2022

      Non Small Cell Lung Cancer Trial in Spain (Nivolumab 360 mg, Paclitaxel 200mg/m2, Carboplatin AUC 6)

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • Nivolumab 360 mg
      • +2 more
      • La Coruña, Coruña, Spain
      • +23 more
      Sep 21, 2021

      Brain Tumors, Metastatic Disease Trial in United States (donepezil HCl, Placebo)

      Completed
      Has Results
      • Brain Tumors
      • Metastatic Disease
      • donepezil hydrochloride
      • Placebo
      • Wichita, Kansas
      • +15 more
      Sep 27, 2021

      HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

      Completed
      • HNSCC
      • Head and Neck Neoplasms
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 27, 2022

      NSCLC Trial in Baltimore (Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides
      • Baltimore, Maryland
        Johns Hopkins University
      Jun 16, 2022

      Low Back Pain Trial (AXOMOVE Therapy Medical Device)

      Not yet recruiting
      • Low Back Pain
      • AXOMOVE Therapy Medical Device
      • (no location specified)
      Jun 15, 2023

      Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (SI-B001, SI-B003)

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • Shanghai, Shanghai, China
        Shanghai Oriental Hospital
      Jan 13, 2023

      Spasticity/Paresis, Cerebral Palsy Trial (device, drug, other, behavioral)

      Not yet recruiting
      • Spasticity/Paresis
      • Cerebral Palsy
      • ESWT
      • +4 more
      • (no location specified)
      Nov 15, 2023

      Sickle Cell Disease, Vaso-occlusive Crisis Trial in Rouen (Erythrocytic parameters and thrombin generation assay measurement)

      Recruiting
      • Sickle Cell Disease
      • Vaso-occlusive Crisis
      • Erythrocytic parameters and thrombin generation assay measurement
      • Rouen, France
        Rouen university Hospital
      May 17, 2022

      Irritable Bowel Syndrome With Constipation Trial (Virtual Reality)

      Not yet recruiting
      • Irritable Bowel Syndrome With Constipation
      • Virtual Reality
      • (no location specified)
      Mar 21, 2023

      90K/Mac-2 BP asIndicator of Early Response to Infliximab Therapy

      Not yet recruiting
      • IBD
      • 90K
      • (no location specified)
      Jul 18, 2023

      Pancreatic Cancer Trial in El Segundo (drug, biological, procedure)

      Unknown status
      • Pancreatic Cancer
      • Aldoxorubicin HCl
      • +14 more
      • El Segundo, California
        Chan Soon-Shiong Institute for Medicine
      Jul 14, 2019

      NSCLC Trial in France, Spain (GB1211, Placebo, Atezolizumab)

      Recruiting
      • Non-Small Cell Lung Cancer
      • Dijon, France
      • +7 more
      Sep 30, 2022